Gurbel, Paul A. http://orcid.org/0000-0002-5461-568X
Bliden, Kevin P.
Kundan, Parshotam
Kraft, Danielle
Parekh, Rueshil
Singh, Sahib
Babu, Aravind D.
Shah, Anika P.
Chaudhary, Rahul
Tantry, Udaya S.
Funding for this research was provided by:
Vectura, Inc
Article History
Accepted: 15 October 2023
First Online: 8 December 2023
Declarations
:
: Dr. Gurbel has received consulting fees and/or honoraria from Bayer, Otitopic/Vectura, Janssen, UpToDate, Cleveland Clinic, Adeno, Wolters Kluwer Pharma, WebMD Medscape, Baron and Budd, North American Thrombosis Forum, Innovative Sciences; institutional research grants from the Haemonetics, Janssen, Bayer, Instrumentation Laboratories, Amgen, Idorsia, Otitopic, Hikari Dx, Novartis, Precision Biologic, Nirmidas Biotech, and R-Pharma International; in addition, Dr. Gurbel has two patents, Detection of restenosis risk in patients issued and Assessment of cardiac health and thrombotic risk in a patient. Dr. Gurbel was an expert witness in a lawsuit associated with Plavix. Other authors report no conflict of interest.